John R Bergquist
Overview
Explore the profile of John R Bergquist including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
524
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Harrison J, Li A, Bergquist J, Ngongoni F, Norton J, Dua M, et al.
HPB (Oxford)
. 2024 Jul;
26(11):1411-1420.
PMID: 39060211
Introduction: Pancreatic pathologies causing portomesenteric occlusion complicate extirpative pancreatic resection due to portomesenteric hypertension and collateral venous drainage. Methods: Patients with portomesenteric occlusion undergoing pancreatectomy were identified between 2007 and...
2.
Harrison J, Li A, Sceats L, Bergquist J, Dua M, Visser B
J Am Coll Surg
. 2024 Jul;
239(6):e7-e12.
PMID: 39051721
No abstract available.
3.
Aldridge T, Mathias K, Bergquist J, Fong Y, Li A, Visser B
Clin Nutr ESPEN
. 2023 Sep;
57:233-238.
PMID: 37739662
Background & Aims: Parenteral nutrition (PN) is commonly utilized to support patients in the perioperative period of major gastrointestinal (GI) surgeries. This study sought to evaluate PN utilization based on...
4.
Leiting J, Hernandez M, Bergquist J, Yonkus J, Abdelrahman A, Torbenson M, et al.
In Vivo
. 2023 Aug;
37(5):1940-1950.
PMID: 37652480
Background/aim: Fibrolamellar hepatocellular carcinoma (FLHCC) is a rare tumor presenting in younger patients without chronic liver disease. Up to 80-100% develop recurrent disease, necessitating additional surgery or systemic treatment. Systemic...
5.
Elser H, Bergquist J, Li A, Visser B
Ann Surg Open
. 2023 Aug;
4(1):e238.
PMID: 37600869
Objective: Characterize the determinants, all-cause mortality risk, and healthcare costs associated with common bile duct injury (CBDI) following cholecystectomy in a contemporary patient population. Background: Retrospective cohort study using nationwide...
6.
Bergquist J, Shariq O, Li A, Worth P, Chatzizacharias N, Soonawalla Z, et al.
Surgery
. 2022 May;
172(2):723-728.
PMID: 35577612
Background: The optimal surgical management of pancreatic neuroendocrine tumors in patients with multiple endocrine neoplasia type 1 is controversial. This study sought to compare clinicopathologic characteristics and outcomes of multiple...
7.
Bergquist J, Starlinger P, Visser B
Hepatobiliary Surg Nutr
. 2021 Nov;
10(5):734-736.
PMID: 34760989
No abstract available.
8.
Ayala C, Li A, Lu A, Wilson A, Bergquist J, Poultsides G, et al.
J Surg Res
. 2021 Oct;
270:195-202.
PMID: 34688991
Background: Enhanced Recovery After Surgery (ERAS) protocols have been successfully instituted for pancreaticoduodenectomy (PD). This study evaluates reasons patients fail to meet length of stay (LOS) and areas for pathway...
9.
10.
Bergquist J, Thiels C, Shubert C, Ivanics T, Habermann E, Vege S, et al.
Cancer Med
. 2021 Jul;
10(17):5925-5935.
PMID: 34289264
Introduction: Although surgical resection is necessary, it is not sufficient for long-term survival in pancreatic ductal adenocarcinoma (PDAC). We sought to evaluate survival after up-front surgery (UFS) in anatomically resectable...